Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0W4N stock hub

LON/0W4N has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0W4Nis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

287M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0W4N

In the news

Latest news · LON/0W4N

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-15

P25 -54.2P50 2.1P75 13.7

ROIC-9.1

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0W4N market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

183

Groups with data

Currency

EUR

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	UK
Employees	250
Employees Change	-5%
Employees Change Percent	-2
Enterprise value	EUR 235.8M
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	DE000A1EWVY8
Last refreshed	2026-05-10
Market cap	EUR 287M
Price	EUR 18.58
Price currency	EUR
Rev Per Employee	155,198.63x
Sector	Healthcare
Sic	2836
Symbol	lon/0W4N
Website	https://www.formycon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-19.67%
EV Earnings	-4.18x
EV/FCF	26.9x
EV/Sales	6.14x
FCF yield	3.05%
P/B ratio	0.82x
P/S ratio	7.4x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-68.49%
EBITDA Margin	-10.83%
FCF margin	22.59%
Gross margin	8.04%
Gross Profit	EUR 3.1M
Gross Profit Growth	-75.89%
Gross Profit Growth Q	241.29%
Gross Profit Growth3 Y	-33.34%
Gross Profit Growth5 Y	-14.73%
Net Income	EUR -56.4M
Net Income Growth Years	1%
Pretax Margin	-203.47%
Profit Margin	-145.46%
Profit Per Employee	EUR -225,756
ROA	-2.52
Roa5y	-3.64
ROCE	-4.44
ROE	-15.03
Roe5y	-5.53
ROIC	-9.05
Roic5y	-12.53

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-21.56%
Cagr3y	-36.3%
Cagr5y	-21.52%
EPS Growth Years	1
FCF Growth Q	-15.33%
OCF Growth Q	-18.54%
OCF Growth10 Y	35.5%
Revenue Growth	-36.17x
Revenue Growth Q	-12.59x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	1.53x
Revenue Growth5 Y	5.34x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.06
Assets	EUR 645.1M
Cash	EUR 60.1M
Current Assets	EUR 108.2M
Current Liabilities	EUR 46.3M
Debt	EUR 8.3M
Debt Equity	EUR 0.02
Debt FCF	EUR 0.95
Equity	EUR 348.2M
Interest Coverage	-9.76
Liabilities	EUR 296.9M
Long Term Assets	EUR 537M
Long Term Liabilities	EUR 250.6M
Net Cash	EUR 51.7M
Net Cash By Market Cap	EUR 18.02
Net Cash Growth	89.77%
Net Debt Equity	EUR -0.15
Net Debt FCF	EUR -5.9
Tangible Book Value	EUR -13M
Tangible Book Value Per Share	EUR -0.74
WACC	8.34

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.33
Inventory Turnover	35.32
Net Working Capital	EUR 3.6M
Quick ratio	1.89
Working Capital	EUR 62.3M
Working Capital Turnover	EUR 0.59

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-21.55%
200-day SMA	22.65
3Y total return	-74.16%
50-day SMA	18.91
50-day SMA vs 200-day SMA	50under200
5Y total return	-70.22%
All Time High	91.86
All Time High Change	-79.77%
All Time High Date	2023-01-09
All Time Low	15.9
All Time Low Change	16.86%
All Time Low Date	2026-03-23
ATR	0.72
Beta	0.65
Ch YTD	-27.56
High	19
High52	31.3
High52 Date	2025-07-28
High52ch	-40.64%
Low	18.54
Low52	15.9
Low52 Date	2026-03-23
Low52ch	16.86%
Ma50ch	-1.75%
Price vs 200-day SMA	-17.98%
RSI	50.74
RSI Monthly	33.06
RSI Weekly	39.23
Sharpe ratio	-0.37x
Sortino ratio	-0.43
Total Return	-1%
Tr YTD	-27.56
Tr1m	4.62%
Tr1w	4.38%
Tr3m	-19.22%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -26.6M
Operating margin	-68.49

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,363,930%
Net Borrowing	49,704,720.8
Shares Insiders	14.23%
Shares Institutions	2.79%
Shares Yo Y	1%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 7.2M
Average Volume	762.95x
Bv Per Share	19.7
CAPEX	EUR -642,939
Ch1m	4.62
Ch1w	4.38
Ch1y	-21.54
Ch3m	-19.22
Ch3y	-74.16
Ch5y	-70.22
Ch6m	-3.33
Change	-4.23%
Change From Open	-2.21
Close	19.4
Days Gap	-2.06
Depreciation Amortization	22,184,602.7
Dollar Volume	35,487.8
Earnings Date	2026-05-28
EBIT	EUR -26.6M
EBITDA	EUR -4.2M
EPS	EUR -3.19
F Score	2
FCF	EUR 8.8M
FCF EV Yield	3.72x
Financing CF	46,832,467
Fiscal Year End	December
Founded	1,999
Income Tax	EUR -22.5M
Investing CF	-32,674,727
Is Primary Listing	0
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Ma150	21.97
Ma150ch	-15.41%
Ma20	18.36
Ma20ch	1.21%
Net CF	23,563,664
Next Earnings Date	2026-05-28
Open	19
P FCF Ratio	32.75
P OCF Ratio	30.51
Position In Range	8.7
Ppne	11,819,793
Price Date	2026-05-08
Relative Volume	2.34x
Revenue	38,799,657x
SBC By Revenue	4.08x
Share Based Comp	1,581,612
Tax By Revenue	-58.01x
Tr6m	-3.33%
Volume	1,910
Z Score	0.71

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0W4N pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0W4N stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0W4N?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.8%

Share of float held by funds and institutions

Insider ownership

+14.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.0%

Negative means the company is buying back shares.

Technical

LON/0W4N momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.7

Neutral momentum band

Price vs 200-day MA

-18.0%

50/200-day relationship not available

Beta (5Y)

0.65

Less volatile than the market

Sharpe ratio

-0.37

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0W4N

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0W4N stock rating?

lon/0W4N is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0W4N analysis?

The full report lives at /stocks/lon/0W4N/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0W4N?

The latest report frames lon/0W4N around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0W4N page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.